Vanguard Group Inc Evolus, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,428,943 shares of EOLS stock, worth $24.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,428,943
Previous 3,318,250 3.34%
Holding current value
$24.8 Million
Previous $30.6 Million 31.11%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$5.77 - $9.73 $638,698 - $1.08 Million
110,693 Added 3.34%
3,428,943 $21.1 Million
Q2 2025

Aug 11, 2025
BUY
$9.1 - $12.22 $766,056 - $1.03 Million
84,182 Added 2.6%
3,318,250 $30.6 Million
Q1 2025

May 09, 2025
BUY
$9.47 - $15.04 $593,428 - $942,466
62,664 Added 1.98%
3,234,068 $38.9 Million
Q4 2024

Feb 11, 2025
SELL
$10.84 - $17.45 $259,368 - $417,526
-23,927 Reduced 0.75%
3,171,404 $35 Million
Q3 2024

Nov 13, 2024
BUY
$10.66 - $17.48 $2.24 Million - $3.67 Million
210,116 Added 7.04%
3,195,331 $51.8 Million
Q2 2024

Aug 13, 2024
BUY
$10.45 - $13.76 $832,917 - $1.1 Million
79,705 Added 2.74%
2,985,215 $32.4 Million
Q1 2024

May 10, 2024
SELL
$9.99 - $14.91 $379,639 - $566,609
-38,002 Reduced 1.29%
2,905,510 $40.7 Million
Q4 2023

Feb 14, 2024
BUY
$7.6 - $10.53 $1.86 Million - $2.58 Million
244,865 Added 9.07%
2,943,512 $31 Million
Q3 2023

Nov 14, 2023
BUY
$7.15 - $10.2 $5.3 Million - $7.56 Million
741,451 Added 37.88%
2,698,647 $24.7 Million
Q2 2023

Aug 14, 2023
BUY
$7.23 - $10.52 $386,544 - $562,441
53,464 Added 2.81%
1,957,196 $14.2 Million
Q1 2023

May 15, 2023
BUY
$7.81 - $11.05 $152,537 - $215,817
19,531 Added 1.04%
1,903,732 $16.1 Million
Q4 2022

Feb 10, 2023
BUY
$6.52 - $8.95 $50,940 - $69,926
7,813 Added 0.42%
1,884,201 $14.2 Million
Q3 2022

Nov 14, 2022
BUY
$7.76 - $13.72 $216,084 - $382,047
27,846 Added 1.51%
1,876,388 $15.1 Million
Q2 2022

Aug 12, 2022
BUY
$10.22 - $13.94 $422,331 - $576,056
41,324 Added 2.29%
1,848,542 $21.4 Million
Q1 2022

May 13, 2022
BUY
$5.22 - $11.78 $364,376 - $822,291
69,804 Added 4.02%
1,807,218 $20.3 Million
Q4 2021

Feb 14, 2022
BUY
$5.37 - $8.38 $236,967 - $369,792
44,128 Added 2.61%
1,737,414 $11.3 Million
Q3 2021

Nov 12, 2021
BUY
$7.36 - $13.67 $119,254 - $221,495
16,203 Added 0.97%
1,693,286 $12.9 Million
Q2 2021

Aug 13, 2021
BUY
$8.42 - $13.96 $14.1 Million - $23.4 Million
1,677,083 New
1,677,083 $21.2 Million

Others Institutions Holding EOLS

# of Institutions
172
Shares Held
50.5M
Call Options Held
175K
Put Options Held
539K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $405M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email